Radiothérapie de faible dose pour la pneumopathie covid-19 : rationnel biologique et revue de la littérature

Mostrar otras versiones (2)

The world has now been facing the coronavirus disease 2019 (COVID-19) pandemic due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) since over a year. If most of clinical presentations are benign, fragile patients are at greater risk of developing severe or fatal lung disease. Man...

Descripción completa

Detalles Bibliográficos
Autores principales: Miran, C., Bonnet, É., Allignet, B., Clippe, S., El Hedi Zouai, M., Bosset, M., Fleury, B., Guy, J.-B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. 2021
Materias:
Mise Au Point
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040522/
https://www.ncbi.nlm.nih.gov/pubmed/33903009
http://dx.doi.org/10.1016/j.canrad.2021.03.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040522/
https://www.ncbi.nlm.nih.gov/pubmed/33903009
http://dx.doi.org/10.1016/j.canrad.2021.03.005

Ejemplares similares